Lilly and Boehringer’s Jardiance Poised for Challenge to AZ’s Market Leader Farxiga in Chronic Kidney Disease: Spherix
Life science launch analyst Spherix reached that conclusion after analyzing the results of two surveys—one of 104 U.S. nephrologists and